Compare XPRO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XPRO | LMAT |
|---|---|---|
| Founded | 1938 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2026 | 2006 |
| Metric | XPRO | LMAT |
|---|---|---|
| Price | $17.60 | $80.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $16.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 753.2K | 272.0K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $1.86 | $14.21 |
| Revenue Next Year | $4.70 | $8.88 |
| P/E Ratio | ★ N/A | $55.96 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $11.60 | $78.27 |
| 52 Week High | $19.23 | $118.01 |
| Indicator | XPRO | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 36.84 |
| Support Level | $15.14 | $78.77 |
| Resistance Level | $18.77 | $88.08 |
| Average True Range (ATR) | 0.73 | 1.92 |
| MACD | -0.11 | 0.52 |
| Stochastic Oscillator | 34.10 | 29.17 |
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA); and Asia-Pacific (APAC). The majority of its revenue is derived from the North and Latin America (NLA) segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.